Legal Representation
Attorney
Jinggao LI
USPTO Deadlines
Next Deadline
140 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 19, 2025
Extension Available
Until December 19, 2024
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 18, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 17, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 17, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Dec 2, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Dec 2, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Dec 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 18, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jun 18, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jun 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 19, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 14, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 17, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Aug 16, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 21, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer
Additional Information
Design Mark
The mark consists of the stylized wording, "JACPOZY" with a 3D hexagon shape to the left.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording JACPOZY has no meaning in a foreign language.
Classification
International Classes
005